| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/18/2007 | WO2007008317A2 Process for preparation of sertraline hydrochloride form i |
| 01/18/2007 | WO2007008200A1 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents |
| 01/18/2007 | WO2007008157A1 New combination 2 |
| 01/18/2007 | WO2007008156A1 A pharmaceutical composition comprising a substituted phenylpropionic acid as a free acid and as tert-butyl amine salt thereof |
| 01/18/2007 | WO2007008155A1 New combination 1 |
| 01/18/2007 | WO2007008154A1 Method for evaluating the effects of smoke on bronchioles |
| 01/18/2007 | WO2007008146A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008145A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008144A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008143A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008142A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008140A1 New pyridine analogues |
| 01/18/2007 | WO2007008119A1 The use of ketoprofen in treating hemorrhoids |
| 01/18/2007 | WO2007008069A2 A method for detecting peptides comprising a cross-b structure |
| 01/18/2007 | WO2007008045A1 Pharmaceutical compositions containing clopidogrel bisulfate |
| 01/18/2007 | WO2007008016A1 A compound comprising prodigiosin isolated from serratia marcescence b-1231 kctc 0386bp for provention and treatment of acute graft-versus-host disease |
| 01/18/2007 | WO2007007997A1 Composition for inhibiting acyl-coa:cholesterol acyltransferase |
| 01/18/2007 | WO2007007971A1 Pharmaceutical compositions comprising sibutramine |
| 01/18/2007 | WO2007007943A1 Pharmaceutical composition for treating of cancer comprising pyridylpyridazine compounds or their transition metal complexes |
| 01/18/2007 | WO2007007919A2 Heterocyclic janus kinase 3 inhibitors |
| 01/18/2007 | WO2007007910A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | WO2007007909A1 Combination drug containing diaryl-substituted 5-membered heterocyclic derivative |
| 01/18/2007 | WO2007007894A1 Eye drop preparation comprising xanthan gum and terpenoid |
| 01/18/2007 | WO2007007890A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 01/18/2007 | WO2007007886A1 An oxime derivative and preparations thereof |
| 01/18/2007 | WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | WO2007007757A1 Pharmaceutical composition containing pparϝ agonist |
| 01/18/2007 | WO2007007737A1 Agent for prevention or treatment of glaucoma |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007007668A1 Therapeutic agent and treatment method for ameliorating uremia |
| 01/18/2007 | WO2007007656A1 Pharmaceutical composition containing thiazolidinedione compound |
| 01/18/2007 | WO2007007628A1 Choline salt crystal of azulene compound |
| 01/18/2007 | WO2007007625A1 Pharmaceutical for prevention of hypersensitivity |
| 01/18/2007 | WO2007007588A1 Compound having cyclic group with planarity as core |
| 01/18/2007 | WO2007007562A1 Polysaccharide produced by microorganism belonging to genus bifidobacterium |
| 01/18/2007 | WO2007007524A1 Inhibitor of enzymatic activity of macrophage migration inhibitory factor |
| 01/18/2007 | WO2007007399A1 Thiazole compound |
| 01/18/2007 | WO2007007327A2 Il-32 modulators |
| 01/18/2007 | WO2007007317A1 Nucleic acid agents for downregulating h19, and methods of using same |
| 01/18/2007 | WO2007007208A2 Nonsteroidal immunomodulating kit and composition and uses thereof |
| 01/18/2007 | WO2007007198A2 Retinoid immunomodulating kit and composition and uses thereof |
| 01/18/2007 | WO2007007162A1 New combination of anti-madcam antibody and antifibrotic caspase inhibitor to treat liver fibrosis |
| 01/18/2007 | WO2007007161A2 Novel bio-active derivatives |
| 01/18/2007 | WO2007007152A2 Anti-madcam antibodies to treat metastatic cancers and chloroma |
| 01/18/2007 | WO2007007149A1 Androgen modulators |
| 01/18/2007 | WO2007007133A2 Composition for treatment of psychosis |
| 01/18/2007 | WO2007007132A1 Aripiprazole salts |
| 01/18/2007 | WO2007007105A1 Use of 3,1ib-cis-dihydrotetrabenazine for the treatment of symptons of huntington' s disease |
| 01/18/2007 | WO2007007076A1 Contact lens care solution |
| 01/18/2007 | WO2007007072A1 5-htx modulators |
| 01/18/2007 | WO2007007069A1 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels |
| 01/18/2007 | WO2007007059A1 Fentanyl formulation containing an essential oil |
| 01/18/2007 | WO2007007057A1 Antagonists of sns sodium channels |
| 01/18/2007 | WO2007007054A1 Phthalamides, succinimides and related compounds and their use as pharmaceuticals |
| 01/18/2007 | WO2007007042A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007007041A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007007040A1 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 01/18/2007 | WO2007006942A1 Thiazole derivatives for the treatment of dyskinesias caused by a chemical treatment |
| 01/18/2007 | WO2007006941A1 Thiazole derivatives for the treatment of restless legs syndrome |
| 01/18/2007 | WO2007006928A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 01/18/2007 | WO2007006814A1 Urea glucokinase activators |
| 01/18/2007 | WO2007006807A1 New derivatives of heptaazaphenalene, methods for obtaining them, and their use as protecting agents against uv radiation |
| 01/18/2007 | WO2007006799A1 Use of sertraline in combination with an alkaloid for treating cancer |
| 01/18/2007 | WO2007006797A1 Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer |
| 01/18/2007 | WO2007006761A1 Dicycloalkylcarbamoyl ureas as glucokinase activators |
| 01/18/2007 | WO2007006760A1 Dicycloalkyl urea glucokinase activators |
| 01/18/2007 | WO2007006738A2 Pharmaceutical composition comprising 2 , 3-disubstituted tropanes for the treatment of disorders of sexual desire |
| 01/18/2007 | WO2007006732A1 Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist) |
| 01/18/2007 | WO2007006716A1 Cysteine protease inhibitors |
| 01/18/2007 | WO2007006715A1 Cysteine protease inhibitors |
| 01/18/2007 | WO2007006714A1 Cysteine protease inhibitors |
| 01/18/2007 | WO2007006707A1 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors |
| 01/18/2007 | WO2007006700A1 Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors |
| 01/18/2007 | WO2007006688A1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/18/2007 | WO2007006677A1 Benzimidazole derivatives as 5-ht6,5-ht24 |
| 01/18/2007 | WO2007006672A1 Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases |
| 01/18/2007 | WO2007006581A2 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/18/2007 | WO2007006566A1 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
| 01/18/2007 | WO2007006561A2 Improved crystalline form of the compound a-348441 |
| 01/18/2007 | WO2007006550A2 Oligomers of straight-chain and unbranched fatty acids, and medicaments containing the same |
| 01/18/2007 | WO2007006549A2 Oligomers of cholesterol, cholesterol sulfate and cholesterol esters, and medicaments containing the same |
| 01/18/2007 | WO2007006547A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006546A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006543A1 Camptothecin analogues, process for their preparation, use and formulations containing them |
| 01/18/2007 | WO2007006533A2 Indolylmaleimide derivatives |
| 01/18/2007 | WO2007006530A1 Use of mglur5 (esp. afq056) in gi (esp. gerd) |
| 01/18/2007 | WO2007006529A1 Transdermal therapeutic system comprising a fragrance |
| 01/18/2007 | WO2007006484A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 01/18/2007 | WO2007006459A1 Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| 01/18/2007 | WO2007006334A1 Clear pharmaceutical aqueous microemulsion comprising propofuol and process for preparation |
| 01/18/2007 | WO2007006308A1 Novel glucopyranose esters and glucofuranose esters of alkyl- fu marates and their pharmaceutical use |
| 01/18/2007 | WO2007006307A2 Novel salts of fumaric acid monoalkylesters and their pharmaceutical use |
| 01/18/2007 | WO2007006232A1 Hyaluronic acid phospholipid complex and preparing method thereof |
| 01/18/2007 | WO2007006221A1 Synergistic time-delaying agent for local anestheic |
| 01/18/2007 | WO2007006212A1 Tetrahydroprotoberberine compounds, the synthetic method and the use thereof |
| 01/18/2007 | WO2007006211A1 Dipeptidyl peptidase iv (ddp iv) inhibitors, preparation methods and uses thereof |
| 01/18/2007 | WO2007006208A1 Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 01/18/2007 | WO2007006203A1 A capsule formulation for treating hypertension and coronary heart disease and process for preparation thereof |
| 01/18/2007 | WO2007006197A1 Use of levo-ornidazole for preparing antiparasitic infection drug |
| 01/18/2007 | WO2007006157A1 Neuroprotective modulation of nmda receptor subtype activities |